Obesity Management Market Research Report- Global Forecast to 2022

Obesity Management Market Research Report- Global Forecast to 2022

ID: MRFR/HC/1997-HCRR | July, 2017 | Region: Global | 75 pages | Half-Cooked Research Reports

Obesity Management Market Information, by Prescription (Weight-loss Medication (orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others); by Surgery (Gastric Bypass Surgery, Laparoscopic Adjustable Gastric Banding (LAGB), Biliopancreatic Diversion with Duodenal Switch, and others); by Lifestyle changes (Dietary Changes, Exercise, and others) - Forecast to 2022


Market Synopsis of Obesity Management Market:


Market Scenario:


Obesity management Market is growing moderately. Changing lifestyle and unhealthy eating habits are leading to the problem of obesity. The population of obese people are increasing globally. Obesity leads to various diseases such as diabetes, hypertension, heart diseases and many others. Drugs manufacturers investing their money in R&D to develop effective anti-obesity drugs. Earlier obesity was considered as problem of high income countries but now it’s shifting towards low-middle income countries. Healthcare solution providers are developing new and innovative solutions for healthcare sector. Hospitals also providing different surgery options according to medical history and condition of the patient. Obesity management Market is expected to grow at the average CAGR of 8.4% during 2015-2022. Obesity management Market is expected to reach US$ 6.2 billion by 2022 from US$ 4.17 billion in 2015. However, several side effects of drugs, regulatory issues and high cost are the major restraints for the market.


Obesity Management Market by Surgery

Obesity Management Market by Surgery


Intended Audience



  • Hospitals and Clinics

  • Anti-obesity Drugs manufacturers and suppliers

  • Weight loss equipment manufacturers and suppliers

  • Government and Independent Regulatory Authorities

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Potential Investors


Segments:                                                                                                                                        


Obesity Management Market has been segmented on the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others. On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others. On the basis of lifestyle changes it is segmented into Dietary changes, Exercise, and others.


Regional Analysis of Obesity Management Market:                   


Considering the global scenario of the market, North America region is believed to be the largest market for Obesity management. Moreover the European market is also growing and second largest market for Obesity management. On the other hand, Asia-Pacific market is expected to grow at significant rate in the Obesity management during the forecasted period. Rest of the World is likely to have a limited but steady growth in the market.


Key Players for Obesity Management Market:                                             


Some of the key players in this market are: Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.)


The report for Obesity Management Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Table of Content                                                                                              

1.         Report Prologue

2.         Introduction

2.1       Definition

2.2       Scope of the Study

2.2.1    Research Objective

2.2.2    Assumptions

2.2.3    Limitations

2.3       Market Structure

2.4.      Market Segmentation

3.         Research Methodology

3.1       Research Process

3.2       Primary Research

3.3       Secondary Research

3.4       Market Size Estimation

3.5       Forecast Model

4.         Market Dynamics

4.1       Drivers

4.2       Restraints

4.3       Opportunities

4.4       Mega Trends

4.5       Macroeconomic Indicators

5.         Market Factor Analysis

5.1       Value Chain Analysis

5.2       Porters Five Forces

5.3       Demand & Supply: Gap Analysis

5.4       Pricing Analysis

5.5       Investment Opportunity Analysis

5.6       Merger and Acquisition Landscape

5.9       Upcoming trends

5.9.1 Market trends

5.9.2 Technological trends

5.9.3 Insurance & Regulations

5.9.4 Others

6.         Global Obesity management Market by Prescription weight-loss medication

7.         Global Obesity management Market by Surgery   

8.         Global Obesity management Market by End User

9.         Global Obesity management Market by Region

9.1       Introduction

9.2       America

9.2.1    North America

9.2.1.1 The US

9.2.1.2 Canada

9.2.2    South America

9.3       Europe

9.3.1    Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.3 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2    Eastern Europe

9.4       Asia

9.4.1    China

9.4.2    India

9.4.3    Japan

9.4.4    South Korea

9.4.5    Rest of Asia

9.5       Pacific

9.6       Rest of the World (RoW)

 

LIST OF TABLES

TABLE 1           GLOBAL OBESITY MANAGEMENT MARKET BY PRESCRIPTION WEIGHT-LOSS MEDICATION

TABLE 2           GLOBAL OBESITY MANAGEMENT MARKET BY SURGERY

TABLE 3           GLOBAL OBESITY MANAGEMENT MARKET BY END USER

TABLE 4           GLOBAL OBESITY MANAGEMENT MARKET BY REGION

 

LIST OF FIGURES

FIGURE 1         RESEARCH PROCESS

FIGURE 2         PORTERS FIVE FORCES MODEL

FIGURE 3         GLOBAL OBESITY MANAGEMENT MARKET, BY PRESCRIPTION WEIGHT-LOSS MEDICATION

FIGURE 4         GLOBAL OBESITY MANAGEMENT MARKET, BY SURGERY

 FIGURE 5        GLOBAL OBESITY MANAGEMENT MARKET, BY END USER

FIGURE 6         GLOBAL OBESITY MANAGEMENT MARKET, BY REGION

FIGURE 7         GLOBAL OBESITY MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2015 (%)